Vital Signs - Recent Advancements in Drug Delivery  Novel Formulations and Technologies Offer Improved Treatment Options

Vital Signs - Recent Advancements in Drug Delivery  Novel Formulations and Technologies Offer Improved Treatment Options

 

RELEASE DATE
13-Aug-2012
REGION
North America
Deliverable Type
Market Research
Research Code: 9561-00-E5-00-00
SKU: HC00655-NA-MR_04128
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00655-NA-MR_04128

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on August 13, 2012, provides an insight in to the recent advancements in drug delivery.

Additionally, a company spotlight is provided for Ratio. Ratio, Inc. is a start-up company focused on the development of a novel hydrogel-powered injectable drug delivery device that is worn like a patch. Reimbursement and regulatory news from the FDA is also provided for week of July 30, 2012.

Table of Contents

This week's issue

This issue of Vital Signs, released on August 13, 2012, provides an insight in to the recent advancements in drug delivery. Additionally, a company spotlight is provided for Ratio. Ratio, Inc. is a start-up company focused on the development of a novel hydrogel-powered injectable drug delivery device that is worn like a patch. Reimbursement and regulatory news from the FDA is also provided for week of July 30, 2012.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-E5-00-00
Is Prebook No